|本期目录/Table of Contents|

[1]马玉玲,裴哲,王晶,等.Wnt蛋白拮抗剂Frzb的cDNA克隆、重组慢病毒构建以及稳定表达细胞株的建立[J].应用与环境生物学报,2014,20(05):775-778.[doi:10.3724/SP.J.1145.2014.03045]
　MA Yuling,PEI Zhe,WANG Jing,et al.cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt Antagonist Frzb[J].Chinese Journal of Applied & Environmental Biology,2014,20(05):775-778.[doi:10.3724/SP.J.1145.2014.03045]
点击复制

Wnt蛋白拮抗剂Frzb的cDNA克隆、重组慢病毒构建以及稳定表达细胞株的建立()
分享到：

《应用与环境生物学报》[ISSN:1006-687X/CN:51-1482/Q]

卷:
20卷
期数:
2014年05期
页码:
775-778
栏目:
研究论文
出版日期:
2014-10-25

文章信息/Info

Title:
cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt Antagonist Frzb
作者:
马玉玲;  裴哲;  王晶;  魏枭;  曾中秋;  陈雨文;  唐亚雄
中国科学院成都生物研究所 成都 610041
Author(s):
MA Yuling;  PEI Zhe;  WANG Jing;  WEI Xiao;  ZENG Zhongqiu;  CHEN Yuwen;  TANG Yaxiong
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China
关键词:
Frzb; 肝癌细胞HepG2; 克隆; 重组慢病毒; 稳定细胞株
Keywords:
Frzb;  HCC HepG2;  cloning;  recombinant lentivirus;  stable cell line
分类号:
Q78 : R966
DOI:
10.3724/SP.J.1145.2014.03045
文献标志码:
A
摘要:
Wnt信号通路的异常活化与人类多种恶性肿瘤的发生密切相关，为探索作为Wnt蛋白拮抗剂sFRP（Secreted frizzled related protein）家族成员之一的Frzb/sFRP3在肝癌细胞中的抗癌潜力，本研究主要通过RT-PCR以及慢病毒表达系统进行了Frzb的cDNA克隆、重组慢病毒构建以及肝癌稳定表达细胞株的建立. 从人正常肝细胞HL-7702中提取总RNA，通过RT-PCR获得Frzb cDNA片段并经测序证实；与此同时，将Frzb cDNA分别构建至以绿色荧光蛋白或嘌呤霉素抗性为报告基因的慢病毒真核表达载体pLVX-IRES-ZsGreen1-Frzb及pLVX-Puro-Frzb，通过酶切和测序获得正确的慢病毒重组表达质粒；其次，通过Lenti-X? Lentiviral Expression Systems将慢病毒重组表达质粒与慢病毒包装质粒psPAX2、pMD2.G共转染HEK293T细胞，48 h后制备重组慢病毒悬液，随后感染HEK293T细胞，分别通过荧光显微镜观察绿色荧光蛋白的表达以及Western blot验证了Frzb（FLAG标签）在细胞中的正确表达；最后，将Frzb重组慢病毒悬液感染肝癌HepG2细胞，经2 ?g/mL嘌呤霉素筛选成功地获得了稳定表达Frzb的细胞株. 以上结果表明慢病毒表达体系对Wnt信号通路的分子靶向药物研究具有重要价值. 图4 参14
Abstract:
Aberrant activation of the Wnt signaling pathway is closely linked to tumorigenesis in a variety of major human malignant tumors. However, the anticancer potential of Frzb/sFrp3, one of the secreted frizzled related protein (sFRP) families, in hepatocellular carcinoma is poorly understood. This research aimed to study the cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt antagonist Frzb. The Frzb cDNA fragments were amplified by reverse transcription polymerase chain reaction (RT-PCR) from the total RNA of normal human liver HL-7702 (L02) cells, which were verified by the direct sequencing of PCR products. Secondly, the Frzb cDNA fragments were subcloned into the pLVX-IRES-ZsGreen1-Frzb or pLVX-Puro-Frzb, containing a fluorescent marker (GFP) or a puromycin resistance gene respectively; and the recombinant lentiviral expression plasmids were further confirmed by double digestion and sequencing. Thirdly, HEK293T cells were co-transfected with the lentiviral expression plasmid, plus packaging plasmid psPAX2 and envelope plasmid pMD2.G by using Lenti-X? Lentiviral Expression Systems to obtain recombinant lentiviral particles at 48 hours after transfection; then the overall titers were evaluated by fluorescence microscopy of GFP expression, and the expression of Flag-tagged Frzb successfully detected by Western blot in the infected HEK293T cells. Finally, HepG2 cells were infected with the recombinant lentiviral particles expressing Frzb and the stable Frzb-transducted HepG2 cell line was successfully established by antibiotic selection with puromycin (2 μg/mL). These findings help to lay a foundation for studies about anticancer activities and molecular mechanisms of Frzb in hepatocellular carcinoma.

参考文献/References:

1 Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence global cancer statistics [J]. Nat Rev Gastroenterol Hepatol, 2013, 10 (1): 34-42
2 Clevers H, Nusse R. Wnt/β-catenin signaling and disease [J]. Cell, 2012, 149 (6): 1192-1205
3 Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology [J]. Future Oncol, 2008, 4 (5): 647-660
4 de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas [J]. Proc Natl Acad Sci USA, 1998, 95 (15): 8847-8851
5 Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas [J]. Oncogene, 2002, 21 (31): 4863-4871
6 Bengochea A, de Souza MM, Lefran?ois L, Le Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P, Scoazec JY, Vitvitski L, Merle P. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma [J]. Br J Cancer, 2008, 99 (1): 143-150
7 Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells [J]. Hepatology, 2004, 39 (6): 1683-1693
8 Lee TH, Tai DI, Cheng CJ, Sun CS, Lin CY, Sheu MJ, Lee WP, Peng CY, Wang AH, Tsai SL. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics [J]. J Biomed Sci, 2006, 13 (1): 27-39
9 Guo Y, Xie J, Rubin E, Tang YX, Lin F, Zi X, Hoang BH. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling [J]. Cancer Res, 2008, 68 (9): 3350-3360
10 Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness [J]. Cancer Res, 2005, 65 (21): 9762-9770
11 苏鹏, 王晶, 安君霞, 朱启彧, 卢晓霞, 唐亚雄. 毛兰素对人肝癌Huh7细胞的抑制作用[J]. 应用与环境生物学报, 2011, 17 (5): 662-665 [Su P, Wang J, An JX, Zhu QY, Lu XX, Tang YX. Inhibitory effect of Erianin on hepatocellular carcinoma (HCC)Huh7 cell [J]. Chin J Appl Environ Biol, 2011, 17 (5): 662-665]
12 Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer [J]. Nat Rev Cancer, 2013, 13 (1): 11-26
13 Shi Y, He B, You L, Jablons DM. Roles of secreted frizzled-related proteins in cancer [J]. Acta Pharmacol Sin, 2007, 28 (9): 1499-1504
14 Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells [J]. Mol Cancer Ther, 2009, 8 (2): 458-468

备注/Memo

备注/Memo:
收稿日期 Received: 2014-03-26 接收日期 Accepted: 2014-04-17 *国家自然科学基金项目（81173095）和四川省国际合作计划（2013HH0014）资助 Supported by the National Natural Science Foundation of China (81173095) and the International Cooperation Program of Sichuan, China (2013HH0014) **通讯作者 Corresponding author (E-mail: tangyx@cib.ac.cn)
更新日期/Last Update: 2014-10-23